Kimberly L Weisgrau
Overview
Explore the profile of Kimberly L Weisgrau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
776
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gardner M, Fellinger C, Kattenhorn L, Davis-Gardner M, Weber J, Alfant B, et al.
Sci Transl Med
. 2019 Jul;
11(502).
PMID: 31341061
A number of simian and simian human immunodeficiency viruses (SIV and SHIV, respectively) have been used to assess the efficacy of HIV-1 vaccine strategies. Among these, SIVmac239 is considered among...
2.
Haase A, Rakasz E, Schultz-Darken N, Nephew K, Weisgrau K, Reilly C, et al.
PLoS One
. 2015 Jun;
10(6):e0129465.
PMID: 26057743
Measures to prevent sexual mucosal transmission are critically needed, particularly to prevent transmission to young women at high risk in the microepidemics in South Africa that disproportionally contribute to the...
3.
Moldt B, Rakasz E, Schultz N, Chan-Hui P, Swiderek K, Weisgrau K, et al.
Proc Natl Acad Sci U S A
. 2012 Oct;
109(46):18921-5.
PMID: 23100539
Most animal studies using passive administration of HIV broadly neutralizing monoclonal antibodies (bnMAbs) have associated protection against high-dose mucosal viral challenge with relatively high serum concentrations of antibody. We recently...
4.
Reynolds M, Piaskowski S, Weisgrau K, Weiler A, Friedrich T, Rakasz E
Cytometry A
. 2010 Aug;
77(11):1059-66.
PMID: 20722008
Deciphering the complex interactions between human and simian immunodeficiency viruses (HIV/SIV) and their host cells is crucial to the development of improved therapies and vaccines. Investigating these relationships has been...
5.
Friedrich T, Piaskowski S, Leon E, Furlott J, Maness N, Weisgrau K, et al.
J Virol
. 2010 Mar;
84(10):5443-7.
PMID: 20219903
Human and simian immunodeficiency viruses (HIV and SIV) downregulate major histocompatibility complex class I (MHC-I) molecules from the surface of infected cells. Although this activity is conserved across viral isolates,...
6.
Hessell A, Rakasz E, Tehrani D, Huber M, Weisgrau K, Landucci G, et al.
J Virol
. 2009 Nov;
84(3):1302-13.
PMID: 19906907
The membrane-proximal external region (MPER) of HIV-1, located at the C terminus of the gp41 ectodomain, is conserved and crucial for viral fusion. Three broadly neutralizing monoclonal antibodies (bnMAbs), 2F5,...
7.
Maness N, Sacha J, Piaskowski S, Weisgrau K, Rakasz E, May G, et al.
J Virol
. 2009 Jul;
83(19):10280-5.
PMID: 19605480
Understanding the correlates of immune protection against human immunodeficiency virus and simian immunodeficiency virus (SIV) will require defining the entire cellular immune response against the viruses. Here, we define two...
8.
Friedrich T, Valentine L, Yant L, Rakasz E, Piaskowski S, Furlott J, et al.
J Virol
. 2007 Jan;
81(7):3465-76.
PMID: 17251286
"Elite controllers" are individuals that durably control human immunodeficiency virus or simian immunodeficiency virus replication without therapeutic intervention. The study of these rare individuals may facilitate the definition of a...